"BETi apabetalone (RVX-208) not only improves the cardiovascular outcomes of patients with type 2 diabetes after acute coronary syndrome,162 but also decreases the risk of atherosclerotic plaque rupture and major adverse cardiac events" (bolding added)
I assume the information in bold is new information???
Koo